Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Entera Bio

CTech 24/7

  • Economy under fire: Israel’s fiscal future hinges on war’s endgame
  • War with Iran? Tel Aviv Stock Exchange shrugs, rises for second day
  • “Outrageous and unprecedented”: Israel slams France over air show weapon ban
  • CTech's War Room: Live Log - June 16, 2025
More stories in CTech

Entera Bio

3 stories about Entera Bio
  • Nasdaq. Photo: Nasdaq

    Fourth Time’s the Charm for Entera Bio IPO

    01.07.18|Dror ReichThe Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each

  • Pills (illustration)

    Entera Bio Files for Nasdaq IPO

    12.11.17|Lilach BaumerThe clinical stage company develops treatments mostly for osteoporosis and bone disorders

  • Orally administrated drugs

    IPO Hopeful Entera Bio Moves to Better Position

    13.09.17|Dror ReichClinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive